Savara Inc (SVRA) ROI
- 2026-06-30: ROI -80.17%.
- 2026-03-31: ROI -62.82%.
- 2025-12-31: ROI -50.99%.
- 2025-09-30: ROI -93.14%.
Complete source-backed roi history.
- Available history
- 2021-09-30 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -80.17% |
| 2026-03-31 | -62.82% |
| 2025-12-31 | -50.99% |
| 2025-09-30 | -93.14% |
| 2025-06-30 | -73.49% |
| 2025-03-31 | -57.60% |
| 2024-12-31 | -48.41% |
| 2022-03-31 | -25.32% |
| 2021-12-31 | -25.28% |
| 2021-09-30 | -25.14% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -50.99% |
| 2021-12-31 | -25.28% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |